Fate Therapeutics, Inc.

Some of the best links we picked up around the internet

CMN Weekly (21 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 21, 2025

Some of the best links we picked up around the internet

CMN Weekly (7 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 7, 2025

Some of the best links we picked up around the internet

CMN Weekly (13 December 2024) - Your Weekly CRISPR...

CMN Weekly

Dec. 13, 2024

Some of the best links we picked up around the internet

CMN Weekly (22 November 2024) - Your Weekly CRISPR...

CMN Weekly

Nov. 22, 2024

Some of the best links we picked up around the internet

CMN Weekly (13 September 2024) - Your Weekly...

CMN Weekly

Sep. 13, 2024

Some of the best links we picked up around the internet

CMN Weekly (16 August 2024) - Your Weekly CRISPR...

CMN Weekly

Aug. 16, 2024

Some of the best links we picked up around the internet

CMN Weekly (10 May 2024) - Your Weekly CRISPR...

CMN Weekly

May. 10, 2024

Some of the best links we picked up around the internet

Fate Therapeutics, Inc.

Solid Tumors, (NCT06241456)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Systemic Lupus Erythematosus, SLE, (NCT06308978)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Relapsed or Refractory B-cell Lymphoma and Chronic Lymphocytic Leukemia, (NCT04245722)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Hematologic Malignancies, (NCT04023071)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Solid Tumors, (NCT04551885)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III

B-Cell Lymphoma, BCL, (NCT05934097)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Relapsed or Refractory B-Cell Lymphoma, BCL, (NCT05950334)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Solid Tumors, (NCT05395052)
Sponsors:
Fate Therapeutics

IND Enabling

Phase I

Phase II

Phase III